how is retatrutide administered Retatrutide: A New Treatment for Weight Management Retatrutide Promises Big Weight Loss,
Description
Ready to take your GLP-1 journey to the next level
The SELECT trial demonstrated that a once-weekly 2.4 mg dose of semaglutide in overweight or obese patients with ASCVD but without T2D resulted in a 20% decrease in MACE
Patients aged 18 years with an HFpEF diagnosis and a subsequent HF admission were included
R.VishnuN.SinghT.Bertonnier-BroutyL.BsharatS.LuanC.et al (2021)
She was initially treated with T3 and dextroamphetamine in addition to lifestyle modification with limited efficacy
